IVIG - Mechanisms of Action, Indications and new Guidelines

被引：0

|

作者：

Enk, A. ^{[1
]}

机构：

[1] Heidelberg Univ, Hautklin, Heidelberg, Germany

来源：

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2015年 / 13卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

MS15/01

引用

收藏

页码：61 / 61

页数：1

相关论文

共 50 条

[31] Spinal anaesthesia - Mechanisms of action, technique, side effects, indications
Hempel, V
ANASTHESIOLOGIE & INTENSIVMEDIZIN, 2001, 42 (7-8): : 619 - 627
[32] Thalidomide: dermatological indications, mechanisms of action and side-effects
Wu, JJ
Huang, DB
Pang, KR
Hsu, S
Tyring, SK
BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (02) : 254 - 273
[33] Recombinant Activated Factor VII: Mechanisms of Action and Current Indications
Franchini, Massimo
Lippi, Giuseppe
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2010, 36 (05): : 485 - 492
[34] Mechanism of action of IVIg in pemphigus
Bystryn, JC
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 118 (04) : 737 - 737
[35] Mechanism of action of IVIg in pemphigus
Bystryn, J
Jiao, D
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (01) : 296 - 296
[36] Mechanism of action of IVIG in ITP
Lazarus, AH
VOX SANGUINIS, 2002, 83 : 53 - 55
[37] Mechanisms of immune regulation by IVIG
Ballow, Mark
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 14 (06) : 509 - 515
[38] Evaluating IVIG Dosing Strategies in Neurologic Indications & Outcomes
Thy Nguyen
Ayish, Doha
Bokhari, Hammad
NEUROLOGY, 2019, 92 (15)
[39] IVIG INDICATIONS IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA
CHAPEL, HM
TRANSFUSION SCIENCE, 1992, 13 (03): : 301 - 308
[40] LMWH - New mechanisms of action
Harenberg, J.
THROMBOSIS RESEARCH, 2009, 123 : S1 - S4

← 1 2 3 4 5 →